diffractaic acid has been researched along with lobaric acid in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Amicosante, G; Bozzi, A; Brisdelli, F; Celenza, G; Garbarino, JA; Nicoletti, M; Perilli, M; Piovano, M; Sellitri, D | 1 |
Anar, M; Budak, H; Ciftci, M; Ozgencli, I | 1 |
2 other study(ies) available for diffractaic acid and lobaric acid
Article | Year |
---|---|
Cytotoxic activity and antioxidant capacity of purified lichen metabolites: an in vitro study.
Topics: 4-Butyrolactone; Anisoles; Antioxidants; Apoptosis; Benzofurans; Caspases; Cell Line, Tumor; Cell Proliferation; Cell Survival; Depsides; Free Radical Scavengers; Humans; Hydroxybenzoates; Lactones; Lichens; Oxidative Stress; Reactive Oxygen Species; Salicylates | 2013 |
Lichen Acids May Be Used as A Potential Drug For Cancer Therapy; by Inhibiting Mitochondrial Thioredoxin Reductase Purified From Rat Lung.
Topics: Animals; Anisoles; Antineoplastic Agents; Cisplatin; Depsides; Dose-Response Relationship, Drug; Doxorubicin; Enzyme Inhibitors; Furans; Hydroxybenzoates; Lactones; Lichens; Lung; Male; Mitochondria; Molecular Structure; Phenylacetates; Rats; Rats, Sprague-Dawley; Salicylates; Structure-Activity Relationship; Thioredoxin-Disulfide Reductase | 2018 |